stenotic and tortuose iliac artery, renal arteries abnormalities ( Figure  2 ), colon ischemia ( Figure 3 ) are anatomic conditions unfit for EVAR [4] . The new generation of devices may extend in the future the indications and overcoming unfit anatomy, so that more patients will be EVAR suitable and the remain open surgery will become increasingly complex. Usually complex anatomy requires suprarenal cross-clamp associated with higher rate of complications (eg: intraoperative blood loss, postoperative renal insufficiency, use of adjunctive renal and/or visceral grafts). Fewer surgeons will perform these repairs and fewer fellows will be able to complete the operation independently after training [5] .
Younger patients without high risk for OR: A continued surveillance after EVAR to detect aneurysm growth, due to endoleak, device migration, or structural failure is recommended [6] . Computed Tomography (CT) studies are routinely used for graft surveillance in EVAR patients, but up to 2% of all cancers in US may be attributable to their radiations [7] . In the EVAR patients the risk of cancer is higher in CT surveillance vs alternative modalities and a higher risk is present in younger people, with highest in those aged 50 to 55 years and lowest in patients aged >/= 80 years [8] . Infected Aneurysm / Primary aortoenteric fistula: The gold standard of treatment for an infected aortic aneurysm is still surgical debridement of infected tissue, followed by in situ revascularization or extra-anatomic grafting and long-term antibiotic therapy. Endovascular repair should be an alternative for high risk patients or used as a bridge while they await an open procedure [9] .
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Connective tissue disease:
The American Heart Association (AHA) guidelines say that stent grafts are controindicated in patients with Marfan Syndrome and related connective tissue disorders. Additionally, although stent grafting in these patients is feasible, post intervention surveillance confirms that the aorta continues to expand [10] .
EVAR failure: Though the incidence is gradually declining, secondary interventions persist as the Achilles' heel of EVAR. The rate of early conversion is about 1.5% (range 0.8%-5.9%) with an average mortality of 12.4%, the rate of late conversion is about 1.9% (range 0.4%-22%) with a mortality rate of 10%. A recent Cochrane review shows that EVAR mortality in short-term is significantly lower than OR, while in long-term there is no more difference [11] . A recent meta-analysis confirms the result in long term and argues that the mortality is related to AAA [12] . These data support the importance of both appropriate surveillance strategy and expert vascular surgeons in highly complex open interventions [13] . 
Conclusion
Although EVAR has revolutionized the AAA treatment, OR should not be left behind. Among all others (unfavourable anatomy, associated pathology, long-term results, treatment in emergency in the peripheral centers, etc) one of the reasons is also the need for OR after EVAR. For the increased number of EVAR procedures performed, is expected un increased as well for complex OR and therefore un appropriate education of young generation of vascular surgeons will be required.
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